Skip to main navigation Skip to search Skip to main content

Objective cough counting in clinical practice and public health: a scoping review

  • Alexandra J. Zimmer
  • , Rishav Das
  • , Patricia Espinoza Lopez
  • , Vaidehi Nafade
  • , Genevieve Gore
  • , César Ugarte-Gil
  • , Kian Fan Chung
  • , Woo Jung Song
  • , Madhukar Pai
  • , Simon Grandjean Lapierre
  • McGill University
  • McGill University
  • Universidad Peruana Cayetano Heredia
  • Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
  • McGill University
  • University of Texas
  • National Heart and Lung Institute
  • Asan Medical Center
  • Centre de Recherche du Centre Hospitalier de l’Université de Montréal
  • Universite de Montreal

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

SummaryQuantifying cough can offer value for respiratory disease assessment and monitoring. Traditionally, patient-reported outcomes have provided subjective insights into symptoms. Novel digital cough counting tools now enable objective assessments; however, their integration into clinical practice is limited. The aim of this scoping review was to address this gap in the literature by examining the use of automated and semiautomated cough counting tools in patient care and public health. A systematic search of six databases and preprint servers identified studies published up to Feb 12, 2025. From 6968 records found, 618 full-text articles were assessed for eligibility, and 77 were included. Five clinical use cases were identified—disease diagnosis, severity assessment, treatment monitoring, health outcome prediction, and syndromic surveillance—with scarce available evidence supporting each use case. Moderate correlations were found between objective cough frequency and patient-reported cough severity (median correlation coefficient of 0.42, IQR 0·38 to 0·59) and quality of life (median correlation coefficient of −0·49, −0·63 to −0·44), indicating a complex relationship between quantifiable measures and perceived symptoms. Feasibility challenges include device obtrusiveness, monitoring adherence, and addressing patient privacy concerns. Comprehensive studies are needed to validate these technologies in real-world settings and show their clinical value. Early feasibility and acceptability assessments are essential for successful integration.

Original languageEnglish
Article number100908
JournalThe Lancet. Digital health
Volume7
Issue number11
DOIs
StatePublished - Nov 2025
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Objective cough counting in clinical practice and public health: a scoping review'. Together they form a unique fingerprint.

Cite this